Sangeetha Venugopal

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Combination Therapy

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Expert review of hematology

American journal of hematology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li, Juan José Rodríguez Sevilla, Sangeetha Venugopal, Samuel Urrutia Argueta, Guillermo Montalban Bravo, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Rashmi Kanagal-Shamana, Irene Gañán-Gómez, Tapan Mahendra Kadia, Gautam Borthakur, Courtney D D DiNardo, Naval G Daver, Elias J Jabbour, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia Manero
Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li, Juan José Rodríguez Sevilla, Sangeetha Venugopal, Samuel Urrutia Argueta, Guillermo Montalban Bravo, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Rashmi Kanagal-Shamana, Irene Gañán-Gómez, Tapan Mahendra Kadia, Gautam Borthakur, Courtney D D DiNardo, Naval G Daver, Elias J Jabbour, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia Manero
Cytogenetic and molecular associations with outcomes in HR-MDS treated with hypomethylating agents plus venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sangeetha Venugopal, Zhuoer Xie, Amer M Zeidan
An overview of novel therapies in advanced clinical testing for acute myeloid leukemia. Expert review of hematology 16 (2) (2023)
Sangeetha Venugopal, Justin M Watts
Olutasidenib: from bench to bedside. Blood advances (2023)
Sangeetha Venugopal, Zhuoer Xie, Amer M Zeidan
An overview of novel therapies in advanced clinical testing for acute myeloid leukemia. Expert review of hematology 16 (2) (2023)
Sangeetha Venugopal, Rory Michael Shallis, Amer M Zeidan
Oral therapy for myelodysplastic syndromes/neoplasms and acute myeloid leukemia: a revolution in progress. Expert review of anticancer therapy (2023)
Sangeetha Venugopal, Zhuoer Xie, Amer M Zeidan
An overview of novel therapies in advanced clinical testing for acute myeloid leukemia. Expert review of hematology 16 (2) (2023)
Sangeetha Venugopal, Zhuoer Xie, Amer M Zeidan
An overview of novel therapies in advanced clinical testing for acute myeloid leukemia. Expert review of hematology 16 (2) (2023)
Sangeetha Venugopal, Zhuoer Xie, Amer M Zeidan
An overview of novel therapies in advanced clinical testing for acute myeloid leukemia. Expert review of hematology (2023)
Sangeetha Venugopal, Zhuoer Xie, Amer M Zeidan
An overview of novel therapies in advanced clinical testing for acute myeloid leukemia. Expert review of hematology (2023)
Sangeetha Venugopal, Courtney D D DiNardo, Sanam Loghavi, Wei Qiao, Farhad Ravandi, Marina Y Konopleva, Tapan Mahendra Kadia, Kapil N Bhalla, Elias J Jabbour, Ghayas C Issa, Walid Macaron, Naval G Daver, Gautam Borthakur, Guillermo Montalban Bravo, Musa Ylimaz, Keyur P Patel, Rashmi Kanagal-Shamana, Kelly Sharon Chien, Abhishek Maiti, Hagop M Kantarjian, Nicholas James Short
Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia. American journal of hematology 97 (12) (2022)
Sangeetha Venugopal, Koichi Takahashi, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Sanam Loghavi, Nicholas James Short, Maro Ohanian, Lucia Masarova, Ghayas C Issa, Xuemei Wang, Bueso-Ramos Carlos, Musa Ylimaz, Tapan Mahendra Kadia, Michael Andreeff, Farhad Ravandi, Marina Y Konopleva, Hagop M Kantarjian, Courtney D D DiNardo
Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy. Blood cancer journal 12 (1) (2022)
Alexandre Bazinet, Faezeh Darbaniyan, Tapan Mahendra Kadia, Sangeetha Venugopal, Rashmi Kanagal-Shamana, Courtney D D DiNardo, Gautam Borthakur, Elias J Jabbour, Naval G Daver, Naveen Pemmaraju, Marina Y Konopleva, Farhad Ravandi, Koiji Sasaki, Kelly S Chien, Danielle Hammond, Sherry A Pierce, Hagop M Kantarjian, Guillermo Garcia Manero, Guillermo Montalban Bravo
A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia. Cancer (2022)
Sangeetha Venugopal, Mahran Shoukier, Marina Konopleva, Courtney D Dinardo, Farhad Ravandi, Nicholas James Short, Michael Andreeff, Gautam Borthakur, Naval G Daver, Naveen Pemmaraju, Koiji Sasaki, Guillermo Montalban Bravo, Kayleigh R Marx, Sherry Pierce, Uday R Popat, Elizabeth J Shpall, Rashmi Kanagal-Shamana, Guillermo Garcia Manero, Hagop M Kantarjian, Tapan Mahendra Kadia
Outcomes in patients with newly diagnosed TP53-mutated acute myeloid leukemia with or without venetoclax-based therapy. Cancer 127 (19) (2021)
Sangeetha Venugopal, Abhishek Maiti, Courtney D D DiNardo, Sanam Loghavi, Naval G Daver, Tapan Mahendra Kadia, Caitlin R Rausch, Yesid Alvarado, Maro Ohanian DO, Koiji Sasaki, Nicholas James Short, Koichi Takahashi, Musa Ylimaz, Farhad Ravandi, Hagop M Kantarjian, Marina Y Konopleva
Decitabine and venetoclax for IDH1/2-mutated acute myeloid leukemia. American journal of hematology 96 (5) (2021)
Sangeetha Venugopal, John O Mascarenhas
Refractory gout in primary myelofibrosis. Blood 133 (23) (2020)